Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP14536.RAUmge2eTRslE0XrC0mvuzERZfUFrTwa7lJgHaTgZjuFc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP14536.RAUmge2eTRslE0XrC0mvuzERZfUFrTwa7lJgHaTgZjuFc130_assertion type Assertion NP14536.RAUmge2eTRslE0XrC0mvuzERZfUFrTwa7lJgHaTgZjuFc130_head.
- NP14536.RAUmge2eTRslE0XrC0mvuzERZfUFrTwa7lJgHaTgZjuFc130_assertion wasGeneratedBy ECO_0000218 NP14536.RAUmge2eTRslE0XrC0mvuzERZfUFrTwa7lJgHaTgZjuFc130_provenance.
- NP14536.RAUmge2eTRslE0XrC0mvuzERZfUFrTwa7lJgHaTgZjuFc130_assertion wasDerivedFrom ctd_human-20130708 NP14536.RAUmge2eTRslE0XrC0mvuzERZfUFrTwa7lJgHaTgZjuFc130_provenance.
- NP14536.RAUmge2eTRslE0XrC0mvuzERZfUFrTwa7lJgHaTgZjuFc130_assertion SIO_000772 15302576 NP14536.RAUmge2eTRslE0XrC0mvuzERZfUFrTwa7lJgHaTgZjuFc130_provenance.
- NP14536.RAUmge2eTRslE0XrC0mvuzERZfUFrTwa7lJgHaTgZjuFc130_assertion evidence source_evidence_curated NP14536.RAUmge2eTRslE0XrC0mvuzERZfUFrTwa7lJgHaTgZjuFc130_provenance.
- NP14536.RAUmge2eTRslE0XrC0mvuzERZfUFrTwa7lJgHaTgZjuFc130_assertion description "[We utilized two sublines of the DU145 human prostate carcinoma cell line that are genetically engineered to differentially activate the EGFR/PLCgamma cascade and are variously invasive in vitro and in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP14536.RAUmge2eTRslE0XrC0mvuzERZfUFrTwa7lJgHaTgZjuFc130_provenance.